Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jinfei Si
Observed name:
Si, Jinfei
Institutions:
Zhejiang Chinese Medical University,
Chinese Academy of Sciences,
Zhejiang Cancer Hospital,
University of Chinese Academy of Sciences
Observed institutions:
Zhejiang Chinese Medical University,
Chinese Academy of Sciences,
Zhejiang Cancer Hospital,
University of Chinese Academy of Sciences
ORCID:
0000-0001-6351-1690
Observed ORCID:
0000-0001-6351-1690
OpenAlex ID:
A5067987141
The effect of EGFR‐TKIs on survival in advanced non‐small‐cell lung cancer with EGFR mutations: A real‐world study
2022
·
Xiaoqing Yu
, Jinfei Si
, et al.
·
Cancer Medicine
·
14
PDF
Immune checkpoint inhibitors beyond first-line progression with prior immunotherapy in patients with advanced non-small cell lung cancer
2023
·
Manyi Xu
, Yue Hao
, et al.
·
Journal of Thoracic Disease
·
12
PDF
Baseline anemia predicts a poor prognosis in patients with non-small cell lung cancer with epidermal growth factor receptor mutations: a retrospective study
2022
·
Jingwen Wei
, Jing Xiang
, et al.
·
BMC Pulmonary Medicine
·
12
PDF
Clinical outcomes of immune checkpoint inhibitor therapy for advanced lung adenosquamous carcinoma
2023
·
Jingwen Wei
, Jing Xiang
, et al.
·
Journal of Thoracic Disease
·
11
PDF
The efficacy of small molecule anti-angiogenic drugs in previously treated Thymic carcinoma
2023
·
Yelan Guan
, Xiaodong Gu
, et al.
·
BMC Cancer
·
10
PDF
Efficacy of immune checkpoint inhibitors in patients with KRAS-mutant advanced non-small cell lung cancer: A retrospective analysis
2023
·
Xiaodong Gu
, Jinfei Si
, et al.
·
Open Medicine
·
10
PDF
Clinical outcomes of immune checkpoint inhibitors to treat non-small cell lung cancer patients harboring epidermal growth factor receptor mutations
2023
·
Jinfei Si
, Yue Hao
, et al.
·
BMC Pulmonary Medicine
·
9
PDF
Treatment outcomes and prognosis of patients with primary and acquired BRAF ‐mutated non‐small cell lung cancer: A multicenter retrospective study
2022
·
Wenxian Wang
, Xiaodong Gu
, et al.
·
Genes Chromosomes and Cancer
·
9
Comparison of efficacy and safety of second‐ and third‐generation TKIs for non‐small‐cell lung cancer with uncommon EGFR mutations
2023
·
Yue Hao
, Manyi Xu
, et al.
·
Cancer Medicine
·
7
PDF
Comparison of the immunotherapy efficacy between invasive mucinous and non-mucinous adenocarcinoma in advanced lung cancer patients with KRAS mutation: a retrospective study
2023
·
Manyi Xu
, Yue Hao
, et al.
·
Medical Oncology
·
7
Efficacy and safety of immune checkpoint inhibitors (ICIs) combined with antiangiogenic therapy for thymic epithelial tumors (TETs): a retrospective study
2023
·
Jing Xiang
, Jinfei Si
, et al.
·
Translational Cancer Research
·
7
PDF
Efficacy of EGFR-Tyrosine Kinase Inhibitors for advanced non-small cell lung cancer patients harboring rare EGFR mutations of exon 18 E709X
2022
·
Yue Hao
, Manyi Xu
, et al.
·
Medical Oncology
·
7
Comparison of Efficacy and Safety of Platinum-Based Chemotherapy as First-Line Therapy between B3 Thymoma and Thymic Carcinoma
2022
·
Yue Hao
, Jinfei Si
, et al.
·
Current Oncology
·
5
PDF
Association of Next Generation Sequencing and Routine Testing With Clinical Outcomes of Advanced Non-small Cell Lung Cancer Patients in a Real-world Setting
2022
·
Zhengbo Song
, Wenxian Wang
, et al.
·
Research Square
PDF
Association of Next Generation Sequencing and Routine Testing with Survival of Advanced Non-Small Cell Lung Cancer Patients in Clinical Practice
2021
·
Wenxian Wang
, Jinfei Si
, et al.
·
Research Square
PDF
Show more works
View as search
Works count:
17
Citation count:
120
H-index:
8
I10-index:
6
Year
Topic
Type